US first lady Jill Biden tests positive for COVID-19. Check out the details

According to a statement made by Kelsey Donohue, the first lady's deputy communication director, "The first lady has tested positive for COVID-19 in an antigen test just now, after testing negative on Tuesday. This shows a positive rebound."

As a result, the US President Joe Biden arrived on Marine One alone while the first lady, who was scheduled to return to the White House on Wednesday with him, remained in Delaware. According to Donohue's statement, the first lady hasn't had any recurrence of illness and will stay in Delaware, where she was once more secluded.

The statement added, "The White House Medical Unit has done contact tracing and close contacts have been contacted." The president tested negative for COVID-19 in an antigen test on Wednesday morning, according to the White House.


He will intensify his "testing cadence," wear a mask for 10 days in indoors and with people, and maintain distance with his wife, according to the White House.



Since the couple's vacation in South Carolina, when she was forced to spend an extra 5 days by herself while he journeyed back to Delaware and Washington, the first lady, 71, has been experiencing COVID-19 issues. The White House claims that she only displayed slight viral symptoms.

On August 15, when she, the president, and members of their family were on a vacation in Kiawah Island, South Carolina, she was found Covid positive for the first time. She remained quarantined in the seaside community until she had two tests that was found negative and given an all-clear to see the president on Sunday at their Rehoboth Beach, Delaware, home.

The couple was scheduled to attend a DNC fundraising event in adjacent Montgomery County, Maryland on Thursday after returning to Washington, but that's no longer happening, at least for her.

The first lady has received two doses of the Pfizer COVID-19 vaccine, just like her husband. She had been given the anti-viral medication Paxlovid, which has been successful in averting major illness and death in people, who are most vulnerable to COVID-19.